ArticleInternational journal of hematology2026

Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL.

Kohei Yamaguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.